Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
GLYC

GlycoMimetics

$10.26

-0.07 (-0.68%)

07:14
12/18/18
12/18
07:14
12/18/18
07:14
Initiation
GlycoMimetics initiated at H.C. Wainwright »

GlycoMimetics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLYC

GlycoMimetics

$11.48

0.03 (0.26%)

08:55
12/03/18
12/03
08:55
12/03/18
08:55
Conference/Events
GlycoMimetics to hold an analyst investor briefing »

Management, along with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

GLYC

GlycoMimetics

$11.48

0.03 (0.26%)

04:55
12/03/18
12/03
04:55
12/03/18
04:55
Conference/Events
GlycoMimetics to hold an analyst investor briefing »

Management, along with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

GLYC

GlycoMimetics

$11.95

-0.15 (-1.24%)

10:16
11/29/18
11/29
10:16
11/29/18
10:16
Conference/Events
GlycoMimetics to hold an analyst investor briefing »

Management, along with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLYC

GlycoMimetics

$11.94

0.34 (2.93%)

09:05
11/19/18
11/19
09:05
11/19/18
09:05
Hot Stocks
GlycoMimetics enrolls first patient in Phase 3 clinical trial of uproleselan »

GlycoMimetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLYC

GlycoMimetics

$12.69

0.13 (1.04%)

07:52
11/02/18
11/02
07:52
11/02/18
07:52
Earnings
Breaking Earnings news story on GlycoMimetics »

GlycoMimetics reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

Over a quarter ago
GLYC

GlycoMimetics

$13.35

0.01 (0.07%)

14:35
10/10/18
10/10
14:35
10/10/18
14:35
Conference/Events
GlycoMimetics management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

GLYC

GlycoMimetics

$14.94

-0.1 (-0.66%)

16:08
08/09/18
08/09
16:08
08/09/18
16:08
Earnings
GlycoMimetics reports Q2 EPS (26c), consensus (34c) »

Reports quarter-end cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

NDAQ

Nasdaq

$95.20

-0.3 (-0.31%)

, GLYC

GlycoMimetics

$16.70

-0.21 (-1.24%)

09:38
07/25/18
07/25
09:38
07/25/18
09:38
Conference/Events
Joint Economic Committee to hold a hearing »

The Committee will hold a…

NDAQ

Nasdaq

$95.20

-0.3 (-0.31%)

GLYC

GlycoMimetics

$16.70

-0.21 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GLYC

GlycoMimetics

$15.99

0.1 (0.63%)

04:55
07/18/18
07/18
04:55
07/18/18
04:55
Conference/Events
GlycoMimetics management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.